Posted on October 11, 2014 by Sitemaster
The precise ability of the various genetic/genomic tests now available to accurately analyze the risk for clinically significant prostate cancer based on biopsy tissue samples is an important factor that all of the different developers and manufacturers of these tests continue to study in greater detail. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: clinical, genetic, genomic, risk, significance, test | 4 Comments »
Posted on July 6, 2012 by Sitemaster
It has long been a tenet of prostate cancer therapy (whether correct or not) that the appearance of evident metastasis (M1 disease) in men with supposedly progressive, micrometastatic (M0) disease is a key event in the management of patients because of the association between evident metastasis and the potential for onset of symptomatic bone disease. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: metastasis, prevalence, significance | 8 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 